Oramed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORMP and other ETFs, options, and stocks.About ORMP
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides.
CEONadav Kidron
CEONadav Kidron
Employees13
Employees13
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2002
Founded2002
Employees13
Employees13
ORMP Key Statistics
Market cap160.98M
Market cap160.98M
Price-Earnings ratio2.65
Price-Earnings ratio2.65
Dividend yield—
Dividend yield—
Average volume157.14K
Average volume157.14K
High today$4.00
High today$4.00
Low today$3.84
Low today$3.84
Open price$4.00
Open price$4.00
Volume136.16K
Volume136.16K
52 Week high$4.22
52 Week high$4.22
52 Week low$1.98
52 Week low$1.98
Stock Snapshot
Oramed Pharmaceuticals(ORMP) stock is priced at $3.92, giving the company a market capitalization of 160.98M. It carries a P/E multiple of 2.65.
During the trading session on 2026-05-06, Oramed Pharmaceuticals(ORMP) shares reached a daily high of $4.00 and a low of $3.84. At a current price of $3.92, the stock is +2.1% higher than the low and still -2.0% under the high.
Trading activity shows a volume of 136.16K, compared to an average daily volume of 157.14K.
The stock's 52-week range extends from a low of $1.98 to a high of $4.22.
The stock's 52-week range extends from a low of $1.98 to a high of $4.22.
People also own
Based on the portfolios of people who own ORMP. This list is generated using Robinhood data, and it’s not a recommendation.